Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.

Despite recent advances in molecular profiling of colorectal cancer (CRC), as of yet this has not translated into an unbiased molecular liquid biopsy profile which can accurately screen for early CRC. In this study we depict the profile of early stage CRC as well as for advanced adenomas (AA) by com...

Full description

Bibliographic Details
Main Authors: Vardit Moshayoff, Ouriel Faktor, Luigi Laghi, Giuseppe Celesti, Tamar Peretz, Dan Keret, Dana Cohen, Eran Israeli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4956030?pdf=render
_version_ 1811326711142285312
author Vardit Moshayoff
Ouriel Faktor
Luigi Laghi
Giuseppe Celesti
Tamar Peretz
Dan Keret
Dana Cohen
Eran Israeli
author_facet Vardit Moshayoff
Ouriel Faktor
Luigi Laghi
Giuseppe Celesti
Tamar Peretz
Dan Keret
Dana Cohen
Eran Israeli
author_sort Vardit Moshayoff
collection DOAJ
description Despite recent advances in molecular profiling of colorectal cancer (CRC), as of yet this has not translated into an unbiased molecular liquid biopsy profile which can accurately screen for early CRC. In this study we depict the profile of early stage CRC as well as for advanced adenomas (AA) by combination of current molecular knowledge with microarray technology, using efficient circulating free plasma RNA purification from blood and RNA amplification technologies. We joined literature search with Affymetrix gene chip experimental procedure to draw the circulating free plasma RNA profile of colorectal cancer disease reflected in blood. The RNA panel was tested by two datasets comparing patients with CRC with healthy subjects and patients with AA to healthy subjects. For the CRC patient cohort (28 CRC cases vs. 41 healthy controls), the ROC analysis of the selected biomarker panel generated a sensitivity of 75% and a specificity of 93% for the detection of CRC using 8-gene classification model. For the AA patient cohort (28 subjects vs. 46 healthy controls), a sensitivity of 60% and a specificity of 87% were calculated using a 2-gene classification model. We have identified a panel of 8 plasma RNA markers as a preliminary panel for CRC detection and subset markers suitable for AA detection. Subjected to extensive clinical validation we suggest that this panel represents a feasible approach and a potential strategy for noninvasive early diagnosis, as a first-line screening test for asymptomatic, average-risk population before colonoscopy.
first_indexed 2024-04-13T14:53:35Z
format Article
id doaj.art-86670ac3d3344e078d0c8c67b2f36dec
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T14:53:35Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-86670ac3d3344e078d0c8c67b2f36dec2022-12-22T02:42:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015952210.1371/journal.pone.0159522Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.Vardit MoshayoffOuriel FaktorLuigi LaghiGiuseppe CelestiTamar PeretzDan KeretDana CohenEran IsraeliDespite recent advances in molecular profiling of colorectal cancer (CRC), as of yet this has not translated into an unbiased molecular liquid biopsy profile which can accurately screen for early CRC. In this study we depict the profile of early stage CRC as well as for advanced adenomas (AA) by combination of current molecular knowledge with microarray technology, using efficient circulating free plasma RNA purification from blood and RNA amplification technologies. We joined literature search with Affymetrix gene chip experimental procedure to draw the circulating free plasma RNA profile of colorectal cancer disease reflected in blood. The RNA panel was tested by two datasets comparing patients with CRC with healthy subjects and patients with AA to healthy subjects. For the CRC patient cohort (28 CRC cases vs. 41 healthy controls), the ROC analysis of the selected biomarker panel generated a sensitivity of 75% and a specificity of 93% for the detection of CRC using 8-gene classification model. For the AA patient cohort (28 subjects vs. 46 healthy controls), a sensitivity of 60% and a specificity of 87% were calculated using a 2-gene classification model. We have identified a panel of 8 plasma RNA markers as a preliminary panel for CRC detection and subset markers suitable for AA detection. Subjected to extensive clinical validation we suggest that this panel represents a feasible approach and a potential strategy for noninvasive early diagnosis, as a first-line screening test for asymptomatic, average-risk population before colonoscopy.http://europepmc.org/articles/PMC4956030?pdf=render
spellingShingle Vardit Moshayoff
Ouriel Faktor
Luigi Laghi
Giuseppe Celesti
Tamar Peretz
Dan Keret
Dana Cohen
Eran Israeli
Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
PLoS ONE
title Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
title_full Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
title_fullStr Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
title_full_unstemmed Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
title_short Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
title_sort feasibility of unbiased rna profiling of colorectal tumors a proof of principle
url http://europepmc.org/articles/PMC4956030?pdf=render
work_keys_str_mv AT varditmoshayoff feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT ourielfaktor feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT luigilaghi feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT giuseppecelesti feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT tamarperetz feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT dankeret feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT danacohen feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple
AT eranisraeli feasibilityofunbiasedrnaprofilingofcolorectaltumorsaproofofprinciple